1 GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme
2 Contents 1. Why good documentation is essential? 2. What constitutes good documentation? 3. Quality management 4. Deviation control 5. Change control 6. Risk management 7. Product quality review 8. Summary
3 Why Good Documentation is essential? An essential part of the quality assurance system and should exist for all aspects of GMP (reference: WHO GMP, Volume 2) Good documentation practice is an expected practice! Correct, complete, current, and consistent information effectively meet customer and stakeholder' requirements Helps to reduce observations raised on inadequate documentation practices.
4 What constitutes Good Documentation? Approve, review and update documents Changes & current revision status of documents identified Relevant versions of applicable documents available at points of use Documents remain legible and readily identifiable Documents of external origin identified and their distribution controlled Prevent unintended use of obsolete documents, and archiving.
5 Observations on poor documentation practices Document error correction not signed/dated, and didn t include a reason for the correction Write-overs, multiple line-through and use of "White-out" or other masking device Sample sequence table and audit trail not documented (if its not documented, it didn t happen) SOP related to production, calibration, storage and maintenance not authorized by the QA head The delegation for the batch release, in case of absence of the QA manager, not recorded / documented Out-of-specification (OOS) procedure not detailed enough; flow chart and /or check-list not available.
6 How are mistakes corrected? Draw a single line through the error Make the correction next to the error Write an explanation for the error Sign and date the correction.
7 Some tips on Good Documentation Practices Records should be completed at time of activity or when any action is taken Superseded documents should be retained for a specific period of time Records should be retained for at least one year after the expiry date of the finished product Concise, legible, accurate and traceable Picture is worth a thousand words Clear examples Don t assume knowledge.
8 Quality Management
9 What is Quality Management An appropriate infrastructure or "quality system", encompassing the organizational structure, procedures, processes and resources; Systematic actions necessary to ensure adequate confidence that a product (or service) will satisfy given requirements for quality. The totality of these actions is termed "quality assurance".
10 Quality Management
11 Considerations for Quality Management To incorporate an approach to doing business that stresses building in quality through techniques such as: design controls, continuous improvement, auditing, management review and risk management. To incorporate a robust quality system encompassing good documentation practices, including but not limited to: handling of complaints, recalls, change controls, deviation controls, vendors qualifications using appropriate risk management tools.
12 Deviation control
13 What is a deviation? A departure from standard practices or specifications resulting in non-conforming material / or processes, with potential to impact on product quality, safety, efficacy or data integrity. Planned and unplanned deviation Different levels of deviation: critical, major, minor
14 How to manage deviations? Regulatory requirement to capture all sorts of deviations evolves in order to maintain the continuous improvement of processes and systems All batch production deviations (planned or unintended) covering all manufacturing facilities, equipments, operations, distribution, procedures, systems and record keeping should be reported and investigated for corrective and preventative action (CAPA) Deviation should be documented when there is a deviation from methods or controls in manufacturing documents, material control documents, and/or standard operating procedures.
16 Considerations for Deviation Management Develop policy on deviation Determine approach i.e. differentiation among various deviations Tracking of deviation Trending of deviation Create database (software based or manual system) to assist in tracking and trending of deviations.
17 Change control
18 Change control Change: any modification to product, document, process, equipment, instrument, system, facility etc. Change control: procedure reviews, verifies, regulates, manages, approves and controls changes made to the existing operating system or facility or process or procedure or document or product of any combination The key principles of change control are understanding and documenting: What was done, why, when, where, by whom, how and Results, including the impact of changes to other processes.
19 How to manage change control Written procedures should be established and maintained to control changes for: Processes, Facilities, Utilities Methods, Validation, Computer systems Training and training materials Regulatory filings and Quality systems Changes should be justified and documented. All changes that have the potential to impact the quality, safety and efficacy should be evaluated, reviewed and approved.
20 Change request form
21 Flow chart of Change control
22 Considerations for Change control According to the nature and extent of the changes, and the effects these changes may have on processes & products: Realistic and based on the risk (critical, major and minor) associated with each change SOP on change control should provide as many examples / scenario as possible for the various changes Impact assessment following implementation of each change Approval from the respective regulatory authority on the changes which has direct impact on the quality, safety and efficacy Tracking to manage all types of changes Periodic review should be done on all changes taken place.
23 Conditions to Change control Revalidation Requalification Increased testing Stability analysis Document change Regulatory action / variation application.
24 Quality Risk Management
25 Quality Risk Management The main risk management process includes: Risk assessment Risk control Risk review Risk communication
26 Overview of a typical quality management process Ref: ICH Q9
27 Considerations for Quality Risk Management No guidance documents specifying what documents and records must be kept by an organization. Our expectations are to scrutinize processes, products, materials, vendors, equipment, facilities, distribution systems using appropriate risk management tools. Following documents and records should at least be available to support a risk management program: policies procedures analysis-specific plans records and reports.
28 Considerations for Quality Risk Management-2 Evaluation of the risk to quality should be based on: Scientific knowledge and Ultimately link to the protection of the patient The level of effort, formality and documentation should be commensurate with the level of risk. Note: WHO Guideline on Quality Risk Management
29 Product Quality Review
30 What is Product Quality Review (PQR) "Regular evaluations of the quality of pharmaceutical products should be conducted with the objective of verifying the consistency of the process and ensuring its continuous improvement (WHO GMP 1.2/l)". "Regular quality reviews of APIs should be conducted with the objective of verifying the consistency of the process. Such reviews should normally be conducted and documented annually and should include at least a review of. (WHO GMP for APIs 2.5)". The EU PQR requires a greater number of items and areas for review as compared with the US product annual review (PAR). Note: A detail section on PQR (similar to the EU GMP) has been included in the revised Annex 3, WHO GMP Guide.
31 Considerations for PQR The PQR should be written in a common language (e.g. English) which must be understood by all the parties involved. The procedure for performing a typical product review involves the review, analysis, and trending of historical data (i.e., data generated in the past 12 months). Data generated from the batch or product should be trended using appropriate statistical techniques (control charts, process capability study) to determine if the process is in control/capable and any need to make changes. Based on the review, an assessment be made whether corrective and preventive action (CAPA) or any revalidation be undertaken, and the same should be completed in a timely and effective manner.
32 Example of control chart Control Chart Worst Case Upper Spec (Acceptance) Limit Control (Action) Level X X X X X X X X X X X X X X X X X X X X X X Target Control (Action) Level Lower Spec (Acceptance) Limit Worst Case Time X = average of a set of observations
33 Example of control chart-2
34 Process Capability Capability Value (C P or C PK ) Translate into < 1.00 Process is not capable 1.00 to 1.33 Product is barely manufacturable 1.34 to 3.00 Process is a good one >3.00 Process is excellent Ref: Establishing the Minimum Process Capability for a Drug-Product Manufacturing Process Dr Paul King.
35 Summary To make a firm commitment to medicines Quality, and Patient Safety and implementation of GMP To operate a robust quality management system Finally, companies should not work only to pre-qualify their pharmaceutical products, rather companies should operate their manufacturing facilities under quality system at all times.
37 Suggested reading WHO, Quality Assurance of Pharmaceuticals, Vol 2, Second Edition /production/en/ OECD Principles of Good Laboratory Practices 1_1_1,00.html Risk Assessment and Risk Management James L. Vesper ICH, Q9 on QRM and Q10 on Quality System
January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal
September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final
Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex
Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance
Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management
Reference of the document X Annexes Date Report on the audit of (audited National Competent Authority) done on : (date of the audit) By. rapporteur 1. Introduction Country information Pharmaceutical industry
ICH Q10 Pharmaceutical Quality System (PQS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Q10 PQS Guideline Background Objectives
Inspected site(s): Activities Carried out: GMP Inspection report Manufacture of Active Substance Manufacture of Finished Medicinal Product Packaging Importing Laboratory Testing Batch Control and Batch
Page 1 of 8 The Royal Veterinary College Introduction Preface Good Research Practice Funding bodies need to be assured of the quality and validity of research they fund and ensure their contractors are
EU GMP Requirements - Quality Systems - Bernd Boedecker GMP Inspectorate of Hannover / Germany at Turkish Ministry of Health Ankara, 20-21 Oct 2009 contact data Bernd Boedecker Staatliches Gewerbeaufsichtsamt
WCC PDA Dinner Meeting Jan 2012 ICH Q10 - Pharmaceutical Quality System Neil Wilkinson NSF-DBA www.nsf-dba.com ICHQ10.1 WCC PDA Dinner Meeting Jan 2012 Your Presenter Partner at NSF-DBA USA Training, Consultancy,
Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working Party on Control
Guidance for Industry: Quality Risk Management Version 1.0 Drug Office Department of Health Contents 1. Introduction... 3 2. Purpose of this document... 3 3. Scope... 3 4. What is risk?... 4 5. Integrating
Corrective and Preventive Actions A Five Step Approach Topics to Be Covered What is CAPA? Governing authority Five steps to a good CAPA process Where companies have difficulty Example citations Recap What
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. email@example.com Overview GMP requirements for Quality Control laboratories
Annex 2 WHO good manufacturing practices for pharmaceutical products: main principles 1 Introduction 79 General considerations 80 Glossary 81 Quality management in the medicines industry: philosophy and
L 262/22 COMMISSION DIRECTIVE 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064587 EudraLex The Rules Governing Medicinal Products
Guide to Good Manufacturing Practice of Cosmetic Products IA-G0048-2 2 APRIL 2016 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS
BASIC CONCEPTS IN QUALITY MANAGEMENT Ivana Ferrero Processing inspector Inspection Report Assessor Stem Cell Transplantation and Cellular Therapy Unit City of Health and Science of Turin - Italy #EBMT2015
Change Management in Development White Paper Introduction/Background In 2008, the International Conference on Harmonization published the ICH tripartite guideline titled, Pharmaceutical Quality System:
Pharmaceutical Quality System Bringing cgmp into the 21 st Century Granite State 15 March 2012 Theresa McCarthy Agenda International Conference on Harmonization ICH Q10 Pharmaceutical Quality System Relationship
10 December 2013 EMA/INS/GCP/600788/2011 Compliance and Inspection Reflection paper on the use of interactive response technologies (interactive voice/web response systems) in clinical trials, with particular
Chapter j 38 Self Assessment 729 QUALITY MANAGEMENT SYSTEM REQUIREMENTS General Requirements 1. Establishing and implementing a documented quality management system 2. Implementing a documented quality
Pharmaceutical Wholesaler Site Inspection Checklist Date and time of inspection: Legal business name and plant name: Location (address): Phone number: Fax number: Email address: Web site URL: Contact Person:
Safeguarding public health New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Tony Orme, Senior GDP Inspector Inspection, Enforcement and Standards Division
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
ICH-GCG Asean Training Workshop on ICH Guidelines Q8,Q9 and Q10 (New Paradigm) Introduction to Q10 Pharmaceutical Quality System Georges FRANCE, Q- IWG Kuala Lumpur, Malaysia 26-28 July 2010 International
1 2 3 5 August 2011 EMA/INS/GCP/600788/2011 Compliance and Inspection 4 5 6 7 Reflection paper on the Use of Interactive Response Technologies (Interactive Voice/Web Response Systems) in Clinical Trials
IVT 9 th Annual Conference Change Control Change Control A Key Element of a Quality System Jerry Lanese Ph.D. CMC The Lanese Group, Inc. 2011 The Lanese Group 1 Will discuss A Quality System What is it
Page 1 of 20 QUALITY MANUAL ISO 9001 Quality Management System Printed copies are not controlled unless marked "CONTROLLED". Upon receipt of this document, discard all previous copies. Page 2 of 20 Approval
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,
Effective Date: 03/08/2011 Page: 1 of 17 Quality Management System Manual Thomas C. West Eric Weagle Stephen Oliver President ISO Management General Manager Representative Effective Date: 03/08/2011 Page:
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
ISO 9001:2000 Gap Analysis Checklist Type: Assessor: ISO 9001 REQUIREMENTS STATUS ACTION/COMMENTS 4 Quality Management System 4.1 General Requirements Processes needed for the quality management system
Page 1 of 20 ISO 9001 (2000) QUALITY MANAGEMENT SYSTEM ASSESSMENT REPORT SUPPLIER/ SUBCONTRACTOR SUPPLIER/ SUBCONTRACTOR NAME: ADDRESS: CITY AND STATE: ZIP CODE: SUPPLIER/MANUFACTURER NO PHONE: DIVISION:
December 2010 EMA/CHMP/ICH/265145/ Committee for medicinal products for human use (CHMP) ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 Step 5 Transmission to CHMP for information December
EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry Version March 2015 QUESTIONS
Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015 *QP Code of Practice 2008 updated Aug15 Page 1 of 13 Code of Practice for Qualified Persons 1. INTRODUCTION 2.
*Changes from the previous QASE noted by "yellow" highlight of block Evaluation Summary Company: Prepared By: Section Element Manual Audit OK Objective Evidence 2.1 Objective of Quality Assurance Program
The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality
GMP Training Course Quality Control 20-21 October 2009 Lesley Graham Senior Inspector (UK) Quality Control GMP in the QC Laboratory Certificates of Analysis Dealing with out of specification results Parametric
Hong Kong Guide to Good Manufacturing Practice for the Secondary Packaging of Pharmaceutical Products Version 1.3 Drug Office, Department of Health. Contents list 1. QUALITY MANAGEMENT... 4 2. PERSONNEL...
The Quality System for Drugs in Germany Prof. Dr. Harald G. Schweim Head of Department for Drug Regulatory Affairs Institute for Pharmacy, University of Bonn Former President of the German Federal Institute
Implementation of ICH Q8, Q9, Q10 Workshop: C Pharmaceutical Quality System International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Disclaimer
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Quality Implementation Working Group on Q8, Q9 and Q10 & (R4) Current version dated
Edwin Lindsay Principal Consultant, Tel: + 44 (0) 7917134922 E-Mail: firstname.lastname@example.org Corrective and Preventative Action (CAPA) is a system of quality procedures required to eliminate the causes
ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE THIS POLICY OUTLINES THE TOP LEVEL REQUIREMENTS TO SUPPORT PRODUCT QUALITY IN THE DEVELOPMENT, MANUFACTURE AND DISTRIBUTION OF ACTIVE PHARMACEUTICAL
Deviation and Out of Specification Handling APV Training Course GMP Requirements June,10th to11th 2004 Istanbul, Turkey Dr. Jürgen Mählitz GMP Inspector Fronhof 10 D-86152 Augsburg Germany Dr. Jürgen Mählitz
Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics
NIST HANDBOOK 150 CHECKLIST Instructions to the Assessor: This checklist addresses the general accreditation criteria prescribed in NIST Handbook 150, NVLAP Procedures and General Requirements (2006 edition).
Improved Utilization of Self-Inspection Programs within the GMP Environment A Quality Risk Management Approach Barbara Jeroncic Self-inspection is a well-established and vital part of the pharmaceutical
FINE LOGISTICS Quality Manual Document No.: 20008 Revision: A 20008 Rev. A FINE LOGISTICS, Quality Manual Page 1 of 24 Quality Manual: Table of contents Number Section Page 1. GENERAL 3 1.1 Index and revision
ISO 9001 Quality Systems Manual Revision: D Issue Date: March 10, 2004 Introduction Micro Memory Bank, Inc. developed and implemented a Quality Management System in order to document the company s best
OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (14) 19 6R MANAGEMENT OF DOCUMENTS AND RECORDS Full document title and reference Management of Documents and Records PA/PH/OMCL
Page 1 of 12 4 Quality Management System 4.1 General Requirements The Peerless Pump Quality Management System shall include: Documented statements of a quality policy and of quality objectives; A quality
INTRODUCTION What auditors should look for: the items listed in these headings that the ISO requirement is met that the requirement is met in the manner described in the organization's documentation Page
g GE Power & Water ISO 9001:2008 Audit Checklist Organization Auditor Date Page 1 Std. 4.1 General s a. Are processes identified b. Sequence & interaction of processes determined? c. Criteria for operation
Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)
This checklist is intended to help laboratories improve the quality of their testing programs with regard to meat and poultry testing samples, in order to ensure those laboratories are at least equal to
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
MHRA GDP Symposium 2013 Novotel London West, London. 4th December 2013 Quality Risk Management An introduction. Steve Todd, Senior GDP Inspector Contents Risk quotations QRM definitions ICH Q9 QRM in the
Page 1 of 34 Institute for Standardization and Name Job Function Date Signature Mimi Kaplan Director, Institute for Ph.D. Standardization and Control of Pharmaceuticals Rami Kariv, Ph.D. Head of GMP Inspectorate
Deviation Handling and Quality Risk Management A note for guidance for the manufacture of prequalified vaccines for supply to United Nations agencies July, 2013 Vaccine Quality and Regulations (VQR), Essential
The The Public Cord Blood Bank Page 1 of 21 TABLE OF CONTENTS INTRODUCTION... 3 WHAT ARE GOOD MANUFACTURING PRACTICES?... 5 1 TOTAL QUALITY... 7 2 PREMISES... 8 3 EQUIPMENT AND MATERIAL... 9 4 PERSONNEL...
Audit Report in the framework of the APIC Audit Programme Company Location Address Country Subject of Audit Audit Date Auditor (lead) Co-Auditor(s) Participants Signature of Auditor(s) Lead Auditor Co-Auditor
Lotlikar et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), 149-154 149 Available online at http://jddtonline.info REVIEW ARTICLE QUALITY RISK MANAGEMENT (QRM): A REVIEW Lotlikar MV Head Corporate
Basic Understanding of Good Manufacturing Practices Requirements and Execution Minda Chiang Hong Kong Society for Quality Jan 2006 1 Outline 1 To know why GMP 2 To know what GMP is 3 To know how to comply
Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers integrating GMP (ICH Q7a) into ISO (9001: 2000) September 2005 Quality Management System - integrating GMP (ICH
State of Control Over the Lifecycle and Process Validation (New and Legacy Products) Grace McNally Branch Chief (acting), Regulatory Policy and Collaboration Branch FDA/CDER/Office of Compliance ICH Q10,
Row Manufacturing Inc. Quality Manual ISO 9001:2008 Row Manufacturing 210 Durham Drive Athens, Alabama 35611 Phone:256.232.4151 Fax:256.232.4133 Page 2 of 33 This Page intentionally left Blank Page 3 of
1. PURPOSE The purpose of this document is to detail the gaps between the superseded standard ISO 9001: 2008 and the current standard ISO 9001: 2015, to assist existing and potential clients assess their